Sage Journals: Discover world-class research

Free access

Research article

First published 2013-2

On-target Effects of GLP-1 Receptor Agonists on Thyroid C-cells in Rats and Mice

Thomas J. Rosol

Toxicologic Pathology

Free access

Research article

First published 2012-4

GLP-1 receptor agonists: A clinical perspective on cardiovascular effects

Dhanwantee Mundil, Alison Cameron-Vendrig, Mansoor Husain

Diabetes & Vascular Disease Research

Free access

Review article

First published 2015-2

GLP-1 receptor agonists: a review of head-to-head clinical studies

Jennifer M. Trujillo, Wesley Nuffer, Samuel L. Ellis

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Review article

First published 2016-12

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders

Jamie Wroge, Nancy Toedter Williams

Annals of Pharmacotherapy

Open access

Review article

First published 2021

GLP-1 receptor agonists: an updated review of head-to-head clinical studies

Jennifer M. Trujillo, Wesley Nuffer, Brooke A. Smith

Therapeutic Advances in Endocrinology and Metabolism

Free access

Research article

First published 2024-9

Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis

Maria-Ioanna Stefanou, Aikaterini Theodorou, Konark Malhotra [...]

European Stroke Journal

Retricted access

Case report

First published 2014-10

Systemic Allergic Reaction to the GLP-1 Receptor Agonist Exenatide

Esther H. Steveling, Bettina Winzeler, Andreas J. Bircher

Journal of Pharmacy Technology

Retricted access

Review article

First published 2024-6

Existing and emerging GLP-1 receptor agonist therapy: Ramifications for diabetic retinopathy screening

George Iype Varughese, Sarita Jacob

Journal of the Royal College of Physicians of Edinburgh

Open access

Review article

First published 2025

GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implications

Mariana M. Ramírez-Mejía, Guadalupe Ponciano-Rodriguez, Mohammed Eslam [...]

Therapeutic Advances in Endocrinology and Metabolism

Open access

Review article

First published 2024

Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysis

Maria-Ioanna Stefanou, Lina Palaiodimou, Aikaterini Theodorou [...]

Therapeutic Advances in Neurological Disorders

Search results